These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
88 related items for PubMed ID: 1316548
1. Characterization of 1,25-dihydroxyvitamin D3 receptor interactions with target sequences in the rat osteocalcin gene. Demay MB, Kiernan MS, DeLuca HF, Kronenberg HM. Mol Endocrinol; 1992 Apr; 6(4):557-62. PubMed ID: 1316548 [Abstract] [Full Text] [Related]
3. DNA sequences downstream from the vitamin D response element of the rat osteocalcin gene are required for ligand-dependent transactivation. Sneddon WB, Bogado CE, Kiernan MS, Demay MB. Mol Endocrinol; 1997 Feb; 11(2):210-7. PubMed ID: 9013768 [Abstract] [Full Text] [Related]
9. Characterization of an enhancer required for 1,25-dihydroxyvitamin D3-dependent transactivation of the rat osteocalcin gene. Sneddon WB, Demay MB. J Cell Biochem; 1999 Jun 01; 73(3):400-7. PubMed ID: 10321839 [Abstract] [Full Text] [Related]
10. Transcriptional synergism between the vitamin D3 receptor and other nonreceptor transcription factors. Liu M, Freedman LP. Mol Endocrinol; 1994 Dec 01; 8(12):1593-604. PubMed ID: 7708050 [Abstract] [Full Text] [Related]
11. Identification and characterization of two proximal elements in the rat osteocalcin gene promoter that may confer species-specific regulation. Heinrichs AA, Banerjee C, Bortell R, Owen TA, Stein JL, Stein GS, Lian JB. J Cell Biochem; 1993 Nov 01; 53(3):240-50. PubMed ID: 8263041 [Abstract] [Full Text] [Related]
12. DNA sequences in the rat parathyroid hormone-related peptide gene responsible for 1,25-dihydroxyvitamin D3-mediated transcriptional repression. Falzon M. Mol Endocrinol; 1996 Jun 01; 10(6):672-81. PubMed ID: 8776727 [Abstract] [Full Text] [Related]
13. Identification of sequence elements in mouse calbindin-D28k gene that confer 1,25-dihydroxyvitamin D3- and butyrate-inducible responses. Gill RK, Christakos S. Proc Natl Acad Sci U S A; 1993 Apr 01; 90(7):2984-8. PubMed ID: 8464915 [Abstract] [Full Text] [Related]
14. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation. Raval-Pandya M, Freedman LP, Li H, Christakos S. Mol Endocrinol; 1998 Sep 01; 12(9):1367-79. PubMed ID: 9731705 [Abstract] [Full Text] [Related]
16. The genomic mechanism of action of 1,25-dihydroxyvitamin D3. Ozono K, Sone T, Pike JW. J Bone Miner Res; 1991 Oct 01; 6(10):1021-7. PubMed ID: 1665675 [Abstract] [Full Text] [Related]
17. Functional analysis of vitamin D response elements in the parathyroid hormone gene and a comparison with the osteocalcin gene. Hawa NS, O'Riordan JL, Farrow SM. Biochem Biophys Res Commun; 1996 Nov 12; 228(2):352-7. PubMed ID: 8920918 [Abstract] [Full Text] [Related]
18. Activation of the human osteocalcin gene by 24R,25-dihydroxyvitamin D3 occurs through the vitamin D receptor and the vitamin D-responsive element. Uchida M, Ozono K, Pike JW. J Bone Miner Res; 1994 Dec 12; 9(12):1981-7. PubMed ID: 7872065 [Abstract] [Full Text] [Related]
19. Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3. Zella LA, Kim S, Shevde NK, Pike JW. Mol Endocrinol; 2006 Jun 12; 20(6):1231-47. PubMed ID: 16497728 [Abstract] [Full Text] [Related]